Evidence map›Paper›PMID 24798008›Full record

ReviewSub-cellular biochemistry2014

Perfringolysin O structure and mechanism of pore formation as a paradigm for cholesterol-dependent cytolysins.

Benjamin B Johnson, Alejandro P Heuck

Abstract readReview
In one paragraph

Review in Sub-cellular biochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Revealing the Mechanism of NLRP3 Inflammatory Pathway Activation through KInternational journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Piceatannol AlleviatesMolecules (Basel, Switzerland) · 2022
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Mechanisms protecting host cells against bacterial pore-forming toxins.Cellular and molecular life sciences : CMLS · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Benjamin B JohnsonDepartment of Biochemistry and Molecular Biology, University of Massachusetts, 710 N. Pleasant St., Lederle GRT, Amherst, MA, 01003, USA.
Alejandro P Heuck
University of Massachusetts Amherst · US

Funding

Molecular Mechanism of Translocon Assembly into Cell Plasma MembranesR01GM097414 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI HEUCK, ALEJANDRO PABLO · 2012 to 2016
$1.5M
NIGMS NIH HHS GM097414NIGMS NIH HHS R01 GM097414
6 · The paper itself

Abstract

Cholesterol-dependent cytolysins (CDCs) constitute a family of pore forming toxins secreted by Gram-positive bacteria. These toxins form transmembrane pores by inserting a large β-barrel into cholesterol-containing membrane bilayers. Binding of water-soluble CDCs to the membrane triggers the formation of oligomers containing 35-50 monomers. The coordinated insertion of more than seventy β-hairpins into the membrane requires multiple structural conformational changes. Perfringolysin O (PFO), secreted by Clostridium perfringens, has become the prototype for the CDCs. In this chapter, we will describe current knowledge on the mechanism of PFO cytolysis, with special focus on cholesterol recognition, oligomerization, and the conformational changes involved in pore formation.

Indexed as

CytotoxinsAmino Acid SequenceAnimalsBacterial ToxinsCell MembraneCholesterolHemolysin ProteinsHumansMolecular Sequence DataMutationProtein BindingProtein Structure, TertiaryBacterial ToxinsCholesterolClostridium perfringens theta-toxinCytotoxinsHemolysin Proteins

Identifiers

PMID24798008
PMCPMC4836178
OpenAlexW2167832951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.